ENST00000402203.5:c.-121+10527T>C

Variant summary

Our verdict is Benign.
<-10 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -12 classification points (ACMG Germline Pathogenicity v2019). BA1BP4_Strong

The ENST00000402203.5(TNRC6B):c.-121+10527T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. Note: ENST00000402203.5 is not a MANE Select or MANE Plus Clinical transcript for TNRC6B; the reported annotation may differ from that of the MANE-designated reference transcript for this gene. The variant allele was found at a cumulative frequency of 0.368 (AC=55,958) in the gnomAD database across 152,086 control chromosomes, including 15,089 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.758. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 15089 hom., cov: 32)

Consequence

TNRC6B
ENST00000402203.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.03

Publications

1 publications found
Variant links:
Genes affected
TNRC6B (HGNC:29190): (trinucleotide repeat containing adaptor 6B) Enables RNA binding activity. Involved in positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening; and regulatory ncRNA-mediated gene silencing. Acts upstream of with a positive effect on miRNA-mediated gene silencing by inhibition of translation. Predicted to be located in cytosol. Predicted to be active in P-body and nucleoplasm. Implicated in subserous uterine fibroid and uterine fibroid. [provided by Alliance of Genome Resources, Jul 2025]
TNRC6B Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • global developmental delay with speech and behavioral abnormalities
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000402203.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Benign. The variant received -12 points.

BP4Computational evidence suggests no impact
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); No splicing predictor data available.; Germline computational verdict: benign (Strong).
BA1Stand-alone benign allele frequency (>5%)
GnomAD effective popmax AF >5% — BA1 stand-alone benign; GnomAD reliable popmax AF = 0.7581 — exceeds 5%% threshold (BA1 applied)

Variant Effect in Transcripts

Automated classification analysis was done for transcript: ENST00000402203.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

TNRC6B NM_001024843.2
HGVSc / HGVSpc.-121+11117T>C
Exon rankIntron 1 of 23
intron
Prot: NP_001020014.1UniProt: Q9UPQ9-2

Ensembl Transcripts

TNRC6B ENST00000402203.5
TSL:1
HGVSc / HGVSpc.-121+10527T>C
Exon rankIntron 1 of 23
intron
Prot: ENSP00000384795.1UniProt: Q9UPQ9-2
TNRC6B ENST00000301923.13
TSL:5
HGVSc / HGVSpc.-121+11117T>C
Exon rankIntron 1 of 23
intron
Prot: ENSP00000306759.9UniProt: Q9UPQ9-2

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 4 sources
GnomAD3 genomes
AF: 0.368
AC:55852
Hom:15035
AN:151968
Cov:32
GnomAD4 genome
AF: 0.368
AC:55958
Hom:15089
AN:152086
Cov:32
TOPMed (Bravo)
AF: 0.383
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.263
AC:154294
Hom:27179
AN:587204
Local & regional cohorts 10 sources
ABraOM SABE-WGS-1171
AF: 0.303
AC:710
Hom:136
AN:2342
ChinaMAP Phase 1
AF: 0.0392
Denmark Genome
AF: 0.203
AC:61
AN:300
GenomeAsia100K
AF: 0.235
AC:818
AN:3478
Korea4K (4,157 Koreans)
AF: 0.0410
AC:298
AN:7232
Qatari Genome
AF: 0.375
AC:66
AN:176
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.0317
AC:3891
Hom:77
AN:122692
Turkish Variome
AF: 0.268
AC:415
Hom:65
AN:1546
UK10K
AF: 0.229
AC:1734
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.0317
AC:284
Hom:3
AN:8960
Showing 14 sources
Tested, but no data found:GnomAD4 exomeIf GnomAD4 is missing, the position is probably not covered by the project.

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Benign2.1
BayesDel_noAF
Benign-0.98
CADD
Benign0.19
DANN
Benign0.42
GPN-Star LLR
N/A4.3
GPN-Star score
N/A-0.092
Mutation Taster
N/A100/0polymorphism (auto)
PhyloP100
Benign-2.0
Showing 8 of 8 scores

Splicing Scores

Pangolin (max)
Benign0.0
Showing 1 of 1 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.